ASPEN-09 - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
A Phase 1b/2, Open-label, Multicenter, Multi Arm Study of Evorpacept in Combination with Anti-cancer Therapies in Advanced / Metastatic Malignancies (ASPEN-09)
Principal Investigator
Carey K. Anders, MD
Medical Oncologist
Protocol Number
IRB:
PRO00119152
NCT:
NCT07007559
Phase
Phase I/II
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment